Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Direct Meds vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

5.4

Direct Meds

Best for listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering
★★★☆☆2.7

Starting at $249/mo

CompoundedSemaglutideTirzepatideSublingual Option
Visit Direct Meds →
8.7

Vytora Health

Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
★★★★☆4.4

Starting at $150/mo

CompoundedBrand-Name Available (Mounjaro + Zepbound)All 50 States + DCLegitScript Approved
Visit Vytora Health →

Side-by-Side Comparison

FeatureDirect MedsVytora Health
Overall Score5.4/10✓8.7/10
Starting Price$249/mo✓$150/mo
Editorial Rating2.7 ★ /5✓4.4 ★ /5
Features5 features✓10 features
States Available0✓51
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warnings1 warning✓None

Pros & Cons

Direct Meds

Pros

  • ✓Both semaglutide and tirzepatide available in injection and sublingual formats
  • ✓All-inclusive pricing with medication, consultations, supplies, and 1–2 day temperature-controlled shipping
  • ✓LegitScript certification confirmed (verified December 2025)
  • ✓Named 503A pharmacy partners: CraftedRx (Warrenton, MO) and ChemistryRx (Folcroft, PA)

Cons

  • ✗FDA warning letter September 9, 2025 for misleading marketing of compounded GLP-1s as equivalent to FDA-approved drugs — compliance status post-warning not publicly documented
  • ✗Extensive Better Business Bureau complaint pattern (rating 1.12/5 across 226 reviews as of April 2026) documenting a hidden 3-month commitment trap: multiple users report being charged $940+ for a 3-month supply when they believed they were purchasing 1 month. Direct Meds disputes the characterization but the complaint volume is material
  • ✗Katalys program name 'Direct Meds GLP-1 Offers Top Funnels' and $280 CPA payout indicate aggressive performance-marketing optimization, which can correlate with conversion-first UX patterns
  • ✗Rating discrepancy: Trustpilot 4.6/5 from 7,500+ reviews vs. BBB 1.12/5 from 226 reviews — suggests either review-solicitation bias or genuine unresolved customer experience issues
  • ✗Not available in Mississippi, Louisiana, or California
  • ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • ✗Incorporated May 2024 — less than 2 years of operational history
  • ✗Auto-renewal continues until manual email cancellation; BBB complaints report retention-department friction and hold times exceeding 15 minutes

Vytora Health

Pros

  • ✓All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
  • ✓Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
  • ✓LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
  • ✓Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
  • ✓Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
  • ✓Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
  • ✓Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
  • ✓Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens

Cons

  • ✗Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
  • ✗Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
  • ✗Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
  • ✗Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
  • ✗Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out Direct Meds with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. Direct Meds remains a solid alternative, especially if you're looking for listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering.

Get Started with Direct Meds →Get Started with Vytora Health →

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Direct Meds and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.